GREY:ATBPF - Post by User
Comment by
GeorgeBasseton Dec 08, 2018 9:10pm
207 Views
Post# 29088061
RE: Wallace likes NO and research
RE: Wallace likes NO and researchGeorgeBasset wrote: What if ...
- NO INCREASES CANCER ? : " Because the C.
parvum–induced inflammation did not change the latency of tumor development in
p53−/−NOS2−/− mice, the rapid tumor development in C.
parvum–treated
p53−/−NOS2+/+ mice is genetic evidence of a role of NO
•. We propose a dose-dependent model of NO
•-mediated modulation of tumorigenesis in p53-deficient mice, in which
an increase in NO• production under inflammatory conditions can inhibit apoptosis, increase proliferation, and modulate the immune profile, giving rise to an internal milieu that is conducive to the tumor growth. "
https://cancerres.aacrjournals.org/content/68/17/7130 - Different NO releasing molecules than those developped at ATE are developed ?
- Chronically ill patients taking a constant dose of NO (an already body synthesized molecule) creates chemical imbalances over the years ?
- The NO molecule gives bad breath and is not comercially viable ?
While we wait to get those answers, Citagenix can keep trying hard at growing ...
" Wallace co-founded
NicOx in 1996, creating the first pharmaceutical company to commercialize
gaseous mediator technology
[...] This board oversaw the development of nitric oxide-releasing NSAIDs."
" Hydrogen sulfide is produced in small amounts by some cells of the
mammalian body and has a number of biological signaling functions. (Only two other such gases are currently known:
nitric oxide (NO) and
carbon monoxide (CO).) "